Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C Szu

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Biopolymers|October 1, 1979
Composite predictions of secondary structures of lac repressorS Bourgeois, R L Jernigan, S C Szu, et al.
Infection and Immunity|June 25, 1998
Phase 1 evaluation of Vibrio cholerae O1, serotype Inaba, polysaccharide-cholera toxin conjugates in adult volunteersR K Gupta, D N Taylor, D A Bryla, et al.
Infection and Immunity|June 1, 1997
Synthesis and immunological properties of Vi and di-O-acetyl pectin protein conjugates with adipic acid dihydrazide as the linkerZ Kossaczka, S Bystricky, D A Bryla, et al.
Infection and Immunity|December 1, 1989
Comparative immunogenicities of Vi polysaccharide-protein conjugates composed of cholera toxin or its B subunit as a carrier bound to high- or lower-molecular-weight ViS C Szu, X R Li, R Schneerson, et al.
Developments in Biological Standardization|December 17, 1998
Standardization may suffice for licensure of conjugate vaccinesJ B Robbins, R Schneerson, S C Szu, et al.
Infection and Immunity|July 1, 1990
Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin AA Fattom, R Schneerson, S C Szu, et al.
Infection and Immunity|November 1, 1995
Characterization of a human monoclonal immunoglobulin M (IgM) antibody (IgMBEN) specific for Vi capsular polysaccharide of Salmonella typhiJ Liao, K G Nickerson, S Bystricky, et al.
Infection and Immunity|August 19, 2000
Vibrio cholerae O139 conjugate vaccines: synthesis and immunogenicity of V. cholerae O139 capsular polysaccharide conjugates with recombinant diphtheria toxin mutant in miceZ Kossaczka, J Shiloach, V Johnson, et al.
Infection and Immunity|October 26, 1999
Syntheses and immunologic properties of Escherichia coli O157 O-specific polysaccharide and Shiga toxin 1 B subunit conjugates in miceE Konadu, A Donohue-Rolfe, S B Calderwood, et al.
The Journal of Infectious Diseases|February 18, 1998
Investigational vaccine for Escherichia coli O157: phase 1 study of O157 O-specific polysaccharide-Pseudomonas aeruginosa recombinant exoprotein A conjugates in adultsE Y Konadu, J C Parke, H T Tran, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Biopolymers|October 1, 1979
Composite predictions of secondary structures of lac repressorS Bourgeois, R L Jernigan, S C Szu, et al.
Infection and Immunity|June 25, 1998
Phase 1 evaluation of Vibrio cholerae O1, serotype Inaba, polysaccharide-cholera toxin conjugates in adult volunteersR K Gupta, D N Taylor, D A Bryla, et al.
Infection and Immunity|June 1, 1997
Synthesis and immunological properties of Vi and di-O-acetyl pectin protein conjugates with adipic acid dihydrazide as the linkerZ Kossaczka, S Bystricky, D A Bryla, et al.
Infection and Immunity|December 1, 1989
Comparative immunogenicities of Vi polysaccharide-protein conjugates composed of cholera toxin or its B subunit as a carrier bound to high- or lower-molecular-weight ViS C Szu, X R Li, R Schneerson, et al.
Developments in Biological Standardization|December 17, 1998
Standardization may suffice for licensure of conjugate vaccinesJ B Robbins, R Schneerson, S C Szu, et al.
Infection and Immunity|July 1, 1990
Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin AA Fattom, R Schneerson, S C Szu, et al.
Infection and Immunity|November 1, 1995
Characterization of a human monoclonal immunoglobulin M (IgM) antibody (IgMBEN) specific for Vi capsular polysaccharide of Salmonella typhiJ Liao, K G Nickerson, S Bystricky, et al.
Infection and Immunity|August 19, 2000
Vibrio cholerae O139 conjugate vaccines: synthesis and immunogenicity of V. cholerae O139 capsular polysaccharide conjugates with recombinant diphtheria toxin mutant in miceZ Kossaczka, J Shiloach, V Johnson, et al.
Infection and Immunity|October 26, 1999
Syntheses and immunologic properties of Escherichia coli O157 O-specific polysaccharide and Shiga toxin 1 B subunit conjugates in miceE Konadu, A Donohue-Rolfe, S B Calderwood, et al.
The Journal of Infectious Diseases|February 18, 1998
Investigational vaccine for Escherichia coli O157: phase 1 study of O157 O-specific polysaccharide-Pseudomonas aeruginosa recombinant exoprotein A conjugates in adultsE Y Konadu, J C Parke, H T Tran, et al.
Pageof 6